Agenda

Friday, May 2, 2025

PLENARY SESSIONS  |  EXHIBITS

Time
Session
7:00 am EDT

Check-In
Irvine Auditorium

Breakfast, Visit Exhibits and View Posters
Houston Hall

8:00 am EDT

Welcome Remarks

Irvine Auditorium
Alison W. Loren, MD, MSCE  |  Penn Medicine 
Joseph W. St. Geme, III, MD  |  Children's Hospital of Philadelphia


PLENARY SESSION 4: The Next Frontier in CAR T Autoimmune Disease

Moderator: David L. Porter, MD  |  Penn Medicine | Symposium Co-Chair
Time
Session
8:15 am EDT

Rationale for B Cell Directed Cell Therapy in Autoimmune Disease

Peter A. Merkel, MD, MPH  |  Penn Medicine

8:35 am EDT

CAR T Cells in Autoimmune Diseases: Novel Insights from Growing Experience

Fabian Mueller, MD | University Hospital of Erlangen

8:55 am EDT

Suppress or Destroy: Two Approaches to Engineer T Cells for the Treatment of Autoimmune Disease

James L. Riley, PhD  |  Penn Medicine

9:15 am EDT

Discussion


PLENARY SESSION 5: Pioneering Novel Frontiers in Stem Cell Transplantation and Engineering 

Moderator: Alexis A. Thompson, MD, MPH  |  Children's Hospital of Philadelphia  |  Symposium Co-Chair
Time
Session
9:25 am EDT

Engineering Immunity: αβ T-Cell Depleted and γδ T-Cell Enhanced Haplo-HSCT for Transplantation and Immunotherapy

Alice Bertaina, MD, PhD  |  Stanford University

9:45 am EDT

From Ex Vivo to In Vivo Gene Therapy

Stefano B. Rivella, PhD  |  Children's Hospital of Philadelphia

10:05 am EDT

Genetically Engineered Hematopoietic Stem Cell Transplantation for Cancer

Saar I. Gill, MD, MBBS, PhD, FRACP  |  Penn Medicine

10:25 am EDT

Discussion


BREAK 

Time
Session
10:35 am EDT

VISIT EXHIBITS  |  VIEW POSTERS
Houston Hall


PLENARY SESSION 6: Location, Location, Location: CAR T in Solid Tumors

Moderator: Carl H. June, MD  |  Penn Medicine  |  Symposium Co-Chair 
Time
Session
10:55 am EDT

Engineered NK Cells for Cancer Immunotherapy: From Bench to Bedside

Irvine Auditorium
Katy Rezvani, MD, PhD  |  MD Anderson Cancer Center

11:10 am EDT

GFRa4 as a CAR-T Cell Target for the Treatment of Medullary Thyroid Cancer

Donald L. Siegel, PhD, MD |  Penn Medicine

11:25 am EDT

The Geography of CAR T cell Therapy: Optimizing Expansion, Persistence, Trafficking and Efficacy

Joseph A. Fraietta, PhD  |  Penn Medicine

11:40 am EDT

Discussion


PLENARY SESSION 7: Celling Advanced Therapies: Navigating the Translation from Academia to Industry 

Bruce L. Levine, PhD  |  Penn Medicine  |  Symposium Co-Chair
Time
Session
11:50 am EDT

Reprogramming CAR T-Cell Therapy for Lymphomas: Innovations in Targeting and Efficacy

Marco Ruella, MD | Penn Medicine

12:10 pm EDT

Towards a Platform for In Vivo Corrective Editing of Ultra-Rare and N-of-1 Metabolic Disorders

Kiran Musunuru, MD, PhD, MPH, ML, MRA  | Penn Medicine

12:30 pm EDT

Vision vs. Execution: Is There a Secret Ingredient in Turning Ideas into Pharmaceutical Formulations?

Dora Mitchell, PhD  | Interius Biotherapeutics

12:50 pm EDT

Discussion

Session speakers and
Carl H. June, MD  |  Penn Medicine  |  Symposium Co-Chair

1:00 pm EDT

CLOSING REMARKS   

Cellicon Valley Co-Chairs

1:05 pm EDT

ADJOURN

Houston Hall
Lunch to Go